Holen Sie sich die Stockscreener-App
38.13
0.16%
-0.013
Handel nachbörslich:
38.06
-0.07
-0.18%
Schlusskurs vom Vortag:
$38.12
Offen:
$38.39
24-Stunden-Volumen:
24,802
Relative Volume:
1.03
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+3.59%
1M Leistung:
-0.80%
6M Leistung:
+5.78%
1J Leistung:
+56.86%
1-Tages-Spanne:
$37.61
$38.39
1-Wochen-Bereich:
$36.66
$38.40
52-Wochen-Spanne:
$23.43
$39.95
Tema Oncology Etf Stock (CANC) Company Profile
Firmenname
Tema Oncology Etf
Sektor
Branche
Telefon
-
Adresse
-
Compare CANC vs VTI, SPY, IVV, VB, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CANC
Tema Oncology Etf
|
38.03 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
369.50 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
750.49 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
753.98 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
292.94 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
730.21 | 124.43B | 0 | 0 | 0 | 0.00 |
Tema Oncology Etf Aktie (CANC) Neueste Nachrichten
CANC Stock Chart | TEMA ONCOLOGY ETF (NASDAQ:CANC) - ChartMill
CANC Stock Price, Quote & Chart | TEMA ONCOLOGY ETF (NASDAQ:CANC) - ChartMill
Why (CANC) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Understanding Momentum Shifts in (CANC) - Stock Traders Daily
Avoiding Lag: Real-Time Signals in (CANC) Movement - Stock Traders Daily
Tema ETFs Surpasses $2 Billion in AUM in Under Three Years - Yahoo Finance
Discipline and Rules-Based Execution in CANC Response - Stock Traders Daily
GNOM, CANC, IBB: Healthcare ETFs Build Long-Term Wealth for Investors - TipRanks
CANC: I Give A Hold Rating To This ETF That Invests In Cancer-Fighting Stocks - Seeking Alpha
CANC: First Look At This Addressing Cancer ETF Results In A Hold Rating (Retired Investor) (NASDAQ:CANC) - Seeking Alpha
Behavioral Patterns of CANC and Institutional Flows - Stock Traders Daily
(CANC) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Biotech stocks and longevity investing: Trends to track - North Scott Press
Biotech Stocks & Longevity Investing: Trends to Track - The Motley Fool
Why Is Cogent Biosciences Stock Surging Monday?Cogent Biosciences (NASDAQ:COGT) - Benzinga
Land and Houses Asset Management launches LHLONGEVITY, investing in innovative cancer treatment stocks. - moneyandbanking.co.th
This Investor Built a $56 Million Position in RAPT Last Quarter. It Was Just Acquired for $58 Per Share - AOL.com
ETFs Investing in Adlai Nortye Ltd. Sponsored ADR Stocks - TradingView
How (CANC) Movements Inform Risk Allocation Models - Stock Traders Daily
2 Under-the-Radar Stocks to Buy and Hold - AOL.com
Healthcare stocks are red-hot. Here are 3 picks from a fund manager up 41% this year. - MSN
GNOM, CANC, IBB: Use Targeted Healthcare ETFs to Build Wealth - TipRanks
F/m High Yield 100 ETF (NASDAQ:ZTOP) Shares Down 0.2% – Time to Sell? - Defense World
Trading Systems Reacting to (CANC) Volatility - Stock Traders Daily
11 Best Cancer Stocks to Invest In Now - Insider Monkey
How Tema Oncology Etf (CANC) Affects Rotational Strategy Timing - Stock Traders Daily
Thrivent Financial for Lutherans Decreases Stake in Tema Oncology ETF $CANC - Defense World
(CANC) and the Role of Price-Sensitive Allocations - Stock Traders Daily
2 Stocks That Could Soar This Year - AOL.com
This Top Dividend Stock Could Achieve a Major Milestone This Year. Is It a Buy? - AOL.com
Responsive Playbooks and the CANC Inflection - Stock Traders Daily
Understanding the Setup: (CANC) and Scalable Risk - Stock Traders Daily
Tema Oncology ETF (NQ: CANC - FinancialContent
Here's Why Biotech ETFs Are Rallying Hard - Zacks Investment Research
Los Angeles Daily NewsTema Oncology ETF (Nasdaq:CANC) Stock Quote - FinancialContent
The Technical Signals Behind (CANC) That Institutions Follow - Stock Traders Daily
Biotech Market Forecast: Top Trends for Biotech in 2026 - Investing News Network
ETFs Investing in Ascentage Pharma Group International Unsponsored ADR Stocks - TradingView — Track All Markets
Tema’s Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance - PharmiWeb.com
The AI Pharma Rally Is Real — And Cancer May Soon Be Chronic, Not Deadly - Sahm
Be Thankful to These ETFs This Year - sharewise.com
Inside the Recent Strength in Biotech ETFs - TradingView
ETFs Investing in Zai Lab Ltd. Sponsored ADR Stocks - TradingView
Finanzdaten der Tema Oncology Etf-Aktie (CANC)
Es liegen keine Finanzdaten für Tema Oncology Etf (CANC) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):